Ro vs Humata Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
Ro is a direct-to-patient telehealth company offering virtual care plus Rx delivery for weight loss, men's health, skincare, and fertility — $7B valuation and Novo Nordisk's preferred partner for Wegovy.
About
Ro is a New York-based direct-to-consumer telehealth company founded in 2017 that connects patients with licensed healthcare providers for virtual consultations and delivers prescription medications directly to their homes. Initially focused on men's sexual health (erectile dysfunction) under the Roman brand, Ro has expanded into a multi-condition platform covering weight management (GLP-1 medications), hair loss, skincare, fertility, and women's health.
Raised $25M (Blue Venture Fund, Optum Ventures, Highmark Ventures). 225+ hospitals. ML recommends which clinical documents to include in prior auth submissions, reducing denials before submission.
About
Humata Health is a prior authorization AI platform serving the provider side of healthcare — helping hospital systems optimize their prior authorization submissions to reduce denial rates before claims are ever sent to payers. The company has raised $25 million from Blue Venture Fund, Optum Ventures, and Highmark Ventures, and is deployed at 225+ hospitals. Founded by an MD, the platform applies ML to recommend the specific clinical documentation that each payer's prior authorization algorithm weights most heavily.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.